主页 /
搜索结果：“MK 1775”

“MK 1775”的搜索结果

Quick View
Niraparib R-enantiomer

Catalog No. A21880
Quick View

添加到收藏
PARP1 inhibitor

Niraparib R-enantiomer (MK-4827 R-enantiomer) is an excellent PARP1 inhibitor with IC50 of 2.4 nM. 了解更多

Bulk Inquiry
Quick View
Niraparib hydrochloride

Catalog No. A18018
Quick View

添加到收藏
PARP1 and PARP2 inhibitor

Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. 了解更多

Bulk Inquiry
Quick View
Niraparib tosylate

Catalog No. A16618
Quick View

添加到收藏
PARP1/PARP2 inhibitor

Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. 了解更多

Product Citations (1)

Bulk Inquiry
- Laurie B Schenkel, .et al. A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants, Cell Chem Biol, 2021, Mar 2;S2451-9456(21)00095-7 PMID: 33705687
Quick View
LMK-235

Catalog No. A14341
Quick View

添加到收藏
HDAC4/5 抑制剂

LMK-235是选择性组蛋白脱乙酰基酶(HDAC) 4和HDAC5抑制剂。了解更多

Bulk Inquiry Free Sample
Quick View
MK-8745

Catalog No. A13396
Quick View

添加到收藏
Aurora Kinase A 抑制剂

MK-8745是一种新的极光特异性抑制剂。当在多种谱系的细胞系中进行体外试验时，它以p53依赖的方式诱导凋亡细胞死亡。了解更多

Bulk Inquiry
Quick View
MK-5108 (VX-689)

Catalog No. A11410
Quick View

添加到收藏
Aurora A Kinase 抑制剂

MK-5108，也称为VX-689，是Aurora A激酶ATP结合位点的竞争性抑制剂。了解更多

Product Citations (1)

Bulk Inquiry
- Wei TW, .et al. Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA, Cancer Res, 2017, Jan 15;77(2):494-508 PMID: 28069801
Quick View
Vorinostat (SAHA)

Catalog No. A10979
Quick View

添加到收藏
HDAC 抑制剂

Vorinostat (SAHA)是HDAC的抑制剂，抑制脱乙酰和导致双方超乙酰化组蛋白和转录因子的积累。了解更多

Product Citations (5)

Bulk Inquiry Free Sample
- Ting-Yu Chang, .et al. A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling, Biomed Pharmacother, 2021, Jun;138:111485 PMID: 33740521
- David Diaz-Carballo, .et al. Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors, Commun Biol, 2021, Mar 3;4(1):276 PMID: 33658617
- Arshdeep Singh, .et al. CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition, Eur J Med Chem, 2021, Apr 5;215:113169 PMID: 33588178
- Shariful Islam, .et al. Resistance to histone deacetylase inhibitors confers hypersensitivity to oncolytic reovirus therapy, Blood Adv, 2020, 4(20): 5297-5310 PMID: 33108458
- Giovanni Bocci, .et al. Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19, ACS Pharmacol Transl Sci, 2020, Oct 14
Quick View
MK-4827 (Niraparib)

Catalog No. A11026
Quick View

添加到收藏
PARP 抑制剂

MK-4827 (Niraparib)是一种新型有效的口服生物可利用的PARP-1和PARP-2抑制剂。了解更多

Product Citations (5)

Bulk Inquiry Free Sample
- Joseph M Gozgit, .et al. PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity, Cancer cell, 2021, Jul 22;S1535-6108(21)00340-8 PMID: 34375612
- Ann-Katrin Hopp, .et al. Mitochondrial NAD+ Controls Nuclear ARTD1-Induced ADP-Ribosylation, Molecular cell, 2021, Jan 21; 81(2): 340?C354 PMID: 33450210
- Bian C, .et al. NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression, Nat Commun, 2019, Feb 11;10(1):693 PMID: 30741937
- Tahira Baloch, .et al. Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1, BMC Cancer, 2019, Jan 10;19(1):44 PMID: 30630446
- Khalid Hilmi, .et al. CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair, Sci Adv, 2017, May; 3(5): e1601898 PMID: 28560323
Quick View
VX-680 (MK-0457, Tozasertib)

Catalog No. A10981
Quick View

添加到收藏
Aurora Kinase 抑制剂

VX-680 (MK-0457,Tozasertib)是一种有效的选择性Aurora激酶小分子抑制剂。了解更多

Product Citations (2)

Bulk Inquiry Free Sample
- Sakamoto K, .et al. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response, Leukemia, 2018, May 23 PMID: 29795241
- W. Joost Lesterhuis, .et al. Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations, Sci Rep, 2015, 5: 12298 PMID: 26193793
Quick View
Hesperadin

Catalog No. A10448
Quick View

添加到收藏
Aurora B Kinase 抑制剂

Hesperadin是一种人极光B抑制剂，IC50为40 nM，用于防止底物磷酸化。它显著降低AMPK、Lck、MKK1、MAPKAP-K1、CHK1和PHK的活性，而不抑制MKK1在体内的活性。了解更多

Product Citations (1)

Bulk Inquiry Free Sample
- Wenbin Ji, .et al. OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases, PLoS One, 2016, 11(4): e0153518 PMID: 27082996